Retatrutide
15mg/vial
Triple receptor agonist (GLP-1, GIP, Glucagon) — high-dose 15mg vial for advanced metabolic research.
Choose dosage
Price per vial
$199.99
15mg/vial
Concentration
15mg/vial
Warehouse
US Domestic
Product Description
Retatrutide 15mg provides a high-concentration vial for advanced research protocols requiring extended or higher-dose triple-receptor agonism across the GLP-1, GIP, and glucagon pathways.
Research Overview
This 15mg format is suited for extended research timelines and high-dose experimental designs exploring maximum receptor engagement across all three incretin/glucagon axes. Research into sustained metabolic modulation, adipose tissue distribution at higher dose ranges, and hepatic glucose dynamics benefits from this concentrated vial format. For in-vitro and laboratory research use only.
Research Applications
Certificate of Analysis (Janoshik)
Research Use Only
This product is intended solely for laboratory research and analytical purposes. Not for human consumption or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA.